Evaluation of the Effects of natural Pomegranate juice (Punica granatum) in patients with covid-19
Not Applicable
Recruiting
- Conditions
- Covid19.U07.1
- Registration Number
- IRCT20150711023153N2
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Written informed consent form
Age 18 years old or above
COVID-19 diagnosis based on polymerase chain reaction (PCR)
Acceptance for random assignment
Willingness to participate in research study
Exclusion Criteria
Pregnancy or lactation
IgA <61 mg/dl
Disseminated intravascular coagulation or any other types of coagulopathy
Severe congestive heart failure by the specialist
Other contraindications prescribed by the specialist
Participate in any clinical trial within the past 30 days prior to enrollment in the present study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interleukin 6. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CBC. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.
- Secondary Outcome Measures
Name Time Method